A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma
Clinical trial NCT06952478 · RECRUITING
Trial details
- NCT number
- NCT06952478
- Sponsor
- Celltrion
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-12
- Primary completion
- 2027-11-15
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.